Pediatrix Medical Group, Inc. beat EPS estimates 81% of the time across 16 reported quarters (13 beats, 3 misses), averaging +10.7% versus consensus. Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result | Call |
|---|---|---|---|---|---|
| Q2 FY26 | $0.54 | $0.58 | +7.4% | Beat | |
| Q1 FY26 | $0.34 | $0.41 | +20.6% | Beat | |
| Q3 FY25 | $0.43 | $0.64 | +48.8% | Beat | |
| Q2 FY25 | $0.40 | $0.51 | +27.5% | Beat | |
| Q1 FY25 | $0.23 | $0.31 | +34.8% | Beat | |
| Q4 FY24 | $0.34 | $0.49 | +44.1% | Beat | |
| Q3 FY24 | $0.35 | $0.41 | +17.1% | Beat | |
| Q2 FY24 | $0.29 | $0.32 | +10.3% | Beat | |
| Q1 FY24 | $0.15 | $0.17 | +13.3% | Beat | |
| Q4 FY23 | $0.30 | $0.29 | -3.3% | Miss | |
| Q3 FY23 | $0.40 | $0.29 | -27.5% | Miss | |
| Q2 FY23 | $0.36 | $0.37 | +2.8% | Beat |
Back to MD overview · MD holders · MD KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.